the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia
Clinical trial NCT05864170 · RECRUITING
Trial details
- NCT number
- NCT05864170
- Sponsor
- Shenzhen Hemogen
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-27
- Primary completion
- 2025-12-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.